Medication info
Glimel 4 mg Tablet (Glimepiride)

Glimel 4 mg Tablet (Glimepiride)

Prescription medicationTabletOral
Ingredient · strength
Glimepiride›4mg / 1 tablet
Manufacturer / importer
Dong-A ST Co., Ltd.
Appearance
This drug is a light blue, rectangular tablet.
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200801333 · Notified 2008.01.31 · Insurance code 642505060

Summary

Main use
Improves blood glucose control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. This medicine is administered orally once daily. Take this medicine before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. Monotherapy - Initial dose and dose titration: For patients who have not previously received drug therapy, start treatment with 1 mg of glimepiride once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, there is little additional effect with doses above 4 mg, although some patients achieved better metabolic control when the dose was increased to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic drug. Monotherapy - Subsequent dose adjustment: As diabetes control improves during treatment, the patient's requirement for this medicine may decrease. Therefore, dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. Monotherapy - Switching from another oral hypoglycemic agent to this medicine: There is no exact dose-equivalence relationship between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, it is recommended to follow the method described under Initial dose. That is, start with 1 mg daily and adjust the dose at intervals of 1 ~ 2 weeks. Consider the efficacy and duration of action of the previous medication. Combination therapy - Combination therapy with insulin: Combination therapy with this medicine and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and start insulin at a low dose, increasing it at approximately weekly intervals according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. The insulin dose should be adjusted periodically while measuring blood glucose and glycated hemoglobin. Combination therapy - Combination therapy with metformin: If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. When this medicine is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for blood glucose control.

Ingredients

Manufacturer
Dong-A ST Co., Ltd.

Efficacy & effects

Improves blood glucose control in type 2 diabetes mellitus

  • Blood sugar control problems in patients with type 2 diabetes
View approved original text

This medicine is used to assist patients with type 2 diabetes in controlling blood sugar levels in conjunction with diet and exercise. It can be administered alone, and if blood sugar control is insufficient with oral hypoglycemic monotherapy, it can be combined with insulin. Additionally, it is used in combination therapy with metformin if control is difficult with sulfonylureas or metformin alone. This helps to effectively improve blood sugar control when used alongside various treatment methods.

How to take

Adult dose

Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. This medicine is administered orally once daily. Take this medicine before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. Monotherapy - Initial dose and dose titration: For patients who have not previously received drug therapy, start treatment with 1 mg of glimepiride once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, there is little additional effect with doses above 4 mg, although some patients achieved better metabolic control when the dose was increased to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic drug. Monotherapy - Subsequent dose adjustment: As diabetes control improves during treatment, the patient's requirement for this medicine may decrease. Therefore, dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. Monotherapy - Switching from another oral hypoglycemic agent to this medicine: There is no exact dose-equivalence relationship between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, it is recommended to follow the method described under Initial dose. That is, start with 1 mg daily and adjust the dose at intervals of 1 ~ 2 weeks. Consider the efficacy and duration of action of the previous medication. Combination therapy - Combination therapy with insulin: Combination therapy with this medicine and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and start insulin at a low dose, increasing it at approximately weekly intervals according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. The insulin dose should be adjusted periodically while measuring blood glucose and glycated hemoglobin. Combination therapy - Combination therapy with metformin: If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. When this medicine is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for blood glucose control.

Precautions

This drug should not be used in patients with insulin-dependent diabetes or those presenting with diabetic ketoacidosis or diabetic coma. Patients with known allergies to this drug or its ingredients, or to sulfonylurea drugs should avoid taking it. There has been no experience with this drug in patients with severe liver or kidney impairment, and insulin treatment is recommended for these patients. Women who are pregnant or may become pregnant, as well as nursing mothers, should not take this drug. Patients with severe infections, before and after surgery, or those with severe trauma may require insulin therapy. Gastrointestinal disorders such as diarrhea or vomiting may lead to poor food absorption and increase the risk of hypoglycemia. This drug contains lactose and should not be used in patients with genetic issues such as galactose intolerance, certain lactase deficiency, or glucose-galactose malabsorption. During the first week of taking this medication, there is a heightened risk of hypoglycemia, so blood sugar levels should be closely monitored. Elderly patients, those with poor nutritional status or irregular eating habits, patients with unbalanced exercise and carbohydrate intake, those with changes in eating patterns, frequent alcohol users, patients with impaired kidney or liver function, those with other endocrine disorders, and patients taking other medications are at a higher risk of hypoglycemia and should be particularly cautious. Hypoglycemia can present with various symptoms such as headache, severe hunger, nausea, fatigue, anxiety, confusion, drowsiness, and loss of consciousness, and in severe cases, can result in a comatose state. If symptoms of hypoglycemia occur, sugar-containing food should be consumed immediately, and if symptoms are severe, medical attention should be sought immediately. Various side effects may arise from this medication, including temporary blurred vision, gastrointestinal disturbances, liver function abnormalities, blood abnormalities, and allergic reactions, so if any unusual symptoms occur, a consultation with a doctor or pharmacist is recommended. This medication should be taken regularly for blood sugar control, and dietary modifications and exercise should also be implemented. To prevent hypoglycemia, it is advisable to always carry a source of sugar (e.g., sugar, fruit juice). When taking other medications concurrently, one should inform their doctor or pharmacist as it may affect blood sugar levels. During pregnancy or breastfeeding, this drug should not be used, and insulin therapy should be considered instead. Overdose may cause hypoglycemia, so immediate vomiting should be induced or appropriate treatment should be sought at a hospital. This drug has not been proven safe and effective for children, and dosage adjustments may be necessary for the elderly depending on their kidney function. Finally, this drug should be stored out of the reach of children and kept in its original container.

Side effects

Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disorders, anxiety, aggression, decreased concentration, decreased agility or activity, depression, confusion, speech abnormalities, aphasia, visual impairment, tremors, incomplete paralysis, sensory disturbances, dizziness, weakness, loss of self-control, temporary mental confusion, brain convulsions, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cold and moist skin, tachycardia, hypertension, palpitations, angina, deep vein issues, blurred vision, fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased liver enzymes, liver dysfunction, biliary secretion disorder, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, neutropenia, agranulocytosis, pancytopenia, itching, urticaria, rash, dyspnea, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergic vasculitis, photosensitivity reactions of the skin, decreased serum sodium concentration, taste disorders, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, joint pain, dyspepsia, facial swelling, erectile dysfunction, facial flushing, gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This drug may be sensitive to air or moisture, so it should be stored in a sealed container. It is recommended to maintain storage temperatures between 1 and 30 degrees Celsius to preserve the drug's efficacy and safety for an extended period.

Appearance and packaging

Appearance

This drug is a light blue, rectangular tablet.

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.